1-3 of 3
Anthony Sabulski
Close
Sort by
Journal Articles

A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA

Clinical Trials & Observations
Sonata Jodele, Christopher E. Dandoy, Paibel Aguayo-Hiraldo, Adam Lane, Ashley Teusink-Cross, Anthony Sabulski, Kana Mizuno, Benjamin L. Laskin, Jason Freedman, Stella M. Davies
Journal: Blood
Blood (2024) 143 (12): 1112–1123.
https://doi.org/10.1182/blood.2023022526
Published: 2024
Includes: Supplemental data
Journal Articles

Emapalumab for Treatment of Impending Graft Failure

Anthony Sabulski, Sonata Jodele, Eleanor Cook, Kasiani Myers, Adam C. Lane, Samppa Ryhanen, Sr., Maria Pia Cefalo, Francesco Quagliarella, Stella M Davies, Ashley Teusink-Cross, Paibel Aguayo-Hiraldo, Jessie L. Alexander, Paul Szabolcs, Mira Kohorst, Tiziana Corsetti, Franco Locatelli, Pietro Merli
Journal: Blood
Blood (2023) 142 (Supplement 1): 114.
https://doi.org/10.1182/blood-2023-181096
Published: 2023
Journal Articles

Obinutuzumab (GA101) Significantly Enhances Cell Death and ADCC Compared to Rituximab Against CD20 + sensitive and Rituximab Resistant B-Cell Non-Hodgkin Lymphoma (NHL) and Lymphoblastic Leukemia (BLL)

Aradhana Awasthi Tiwari, PhD, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Danielle Glassman, Anthony Sabulski, Matthew J. Barth, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2012) 120 (21): 4865.
https://doi.org/10.1182/blood.V120.21.4865.4865
Published: 2012